Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -5.80 (-5.32%)
Bid:
103.00
Ask:
104.20
Spread: 1.20 (1.165%)
Market Cap: £169.19m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

28 Oct 2014 07:00

RNS Number : 4095V
Synthomer PLC
28 October 2014
 



28th October 2014

 

Synthomer plc

 

Interim Management Statement

 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 July to 28 October 2014.

 

Trading

 

At our interim results on August 11th 2014, we reported firmer demand in our European and North America (ENA) segment, particularly in construction. Unfortunately this improved demand trend has not persisted through the third quarter and volumes, excluding business that we deliberately exited in compounds as reported in half one, were down 3% in ENA. Despite this, unit cash margins continued to firm as a result of our active margin management strategy, and year-to-date average margins in ENA are now ahead of the 2013 average. However, on a local currency basis, as at the end of the third quarter, year-to-date operating profit was slightly down on the prior year.

 

In our Asia and Rest of the World (ARW) segment, volumes increased by 1.3% in the quarter. Volumes have been impacted somewhat by our market activities to improve unit cash margins in the nitrile business, where we have made good progress. We remain positive about continuing demand growth in the nitrile latex market.

 

Financial Position

 

The balance sheet remains in a strong position with the net debt / EBITDA ratio at approximately 1x.

 

We completed the purchase of the other 50% of our EKA Synthomer JV in Finland in October from Akzo Nobel for €5 million. The entity has some €6 million of debt at the transaction date which will be consolidated at the year end, meaning year end net debt for the Group will be slightly higher than previous expectations, and is likely to be similar to the mid-year position.

 

Consistent with our capital management policy articulated at the interim results, if excess capital has not been deployed for either bolt-on acquisitions or capital expenditure, at the year end the Board will consider a one-off capital return to shareholders to maintain an efficient balance sheet.

 

Outlook

At current run rates and given the current demand environment in Europe, the Board now expects full year profit-before-tax to be slightly below current consensus1. We are cautious about performance in Europe given recent economic developments, and should this impact demand further than currently anticipated in the fourth quarter, then profit-before-tax is likely to be around the lower end of the current consensus range2.

 

1. Company compiled 2014 consensus PBT: £87.8 million

2. Company compiled 2014 consensus PBT range: £81.3million - £90.3 million

 

  

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rebecca Hall

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

 

The company will host a conference call for analysts at 8.30am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUBVNRSRARUAA
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.